Goldman Sachs backs clinical trial services in the cloud with $230M equity play amid decentralized trial craze
Goldman Sachs invest $230M in CRO on the back of the decentralised trials craze CONTEXT: Goldman Sachs joins the decentralised trial Gold rush to invest in the contract clinical research Continue Reading